Teresa DeLuca - 19 May 2022 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role: Director
Signature: /s/ Teresa DeLuca
Issuer symbol: ATNF
Transactions as of: 19 May 2022
Net transactions value: $0
Form type: 4
Filing time: 23 May 2022, 16:30:51 UTC
Previous filing: 25 Mar 2022
Next filing: 24 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ATNF	Common Stock						5,000	19 May 2022	Direct
holding	ATNF	Common Stock						2,500	19 May 2022	By Trust	F1
holding	ATNF	Common Stock						2,500	19 May 2022	By Trust	F2
holding	ATNF	Common Stock						2,500	19 May 2022	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATNF	Non-Qualified Stock Option (right to buy)	Award	$0	+21,000		$0.000000	21,000	19 May 2022	Common Stock	21,000	$1.36	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee.
F2	Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee.
F3	Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
F4	The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.